Health
Red flags for colorectal cancer that warrant screenings before 45 years of age
NEWYou can now listen to Fox News articles!
Colorectal cancer (CRC) is now the leading cause of cancer death in adults under 50 and the second leading cause of cancer death in the U.S., highlighting the importance of routine screenings.
Adults 65 and younger comprise nearly half (45%) of all new cases — a significant increase from 27% in 1995, according to a report from the American Cancer Society.
“Once considered a disease that primarily affected people over 50, we are now seeing increasing diagnoses in patients in their 20s, 30s and 40s — making it even more important not to dismiss symptoms based on age alone,” Dr. Timothy Cannon, director of the Molecular Tumor Board and co-director of the Gastrointestinal Cancer Program at Inova in Virginia, told Fox News Digital.
SPIKE IN DEADLY CANCER BEFORE 50 LINKED TO COMMON CONVENIENCE FOODS
Official health agencies recommend that CRC screenings start at age 45 and continue through age 75 for adults at “average risk.”
Stool-based tests can be used to detect blood or DNA changes, potential indicators of cancer. Depending on the type of stool test, it can be performed every one to three years.
Colorectal cancer is now the leading cause of cancer death in adults under 50 and the second leading cause of cancer death in the U.S. (iStock)
A colonoscopy is a medical procedure that allows a doctor to examine the inside of the patient’s colon and rectum using a thin, flexible tube with a camera on the end. For average-risk adults, a colonoscopy is typically done every 10 years.
“Colonoscopy remains the gold standard because it not only detects cancer early, but can also prevent it by identifying and removing precancerous polyps,” Cannon said.
JAMES VAN DER BEEK’S DEATH HIGHLIGHTS ALARMING COLON CANCER RISE IN YOUNGER ADULTS
Dr. Michael Martin, a California physician, emphasized that colonoscopy is generally preferred for younger patients who are clearly at higher risk.
“Stool-based tests are appropriate screening options for average-risk adults, but they are not the best choice for people with significant family history, inflammatory bowel disease, hereditary syndromes or alarm symptoms,” he told Fox News Digital. “If symptoms are present, the goal is not screening but diagnosis, and colonoscopy is usually the more appropriate test.”
3 reasons to get screened before 45
Doctors may suggest earlier screenings for people who fall into the following higher-risk groups.
Strong family history
“A family history can make screening earlier and more frequent,” Martin told Fox News Digital.
The American College of Gastroenterology recommends early screening if one first-degree relative is diagnosed with colorectal cancer or an advanced polyp before age 60, or if two first-degree relatives are diagnosed at any age.
A colonoscopy is a medical procedure that allows a doctor to examine the inside of the patient’s colon and rectum using a thin, flexible tube with a camera on the end. (iStock)
“They should generally start colonoscopy at age 40 or 10 years before the youngest affected relative’s diagnosis, whichever comes first,” Martin said. “In that setting, repeat the colonoscopy every five years is then generally recommended.”
Critical symptoms
Cannon listed the following red flags that warrant earlier screenings.
NEARLY 40% OF CANCERS CAN BE PREVENTED WITH 3 LIFESTYLE CHANGES, STUDY FINDS
- Rectal bleeding with bright-red blood
- Dark or black stools
- Blood in the stool
- Persistent changes in bowel habits, such as new constipation or diarrhea
- Unexplained iron-deficiency anemia
- Ongoing abdominal pain or cramping
- Unexplained weight loss
- Persistent sensation that the bowel is not emptying fully
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“While many of these symptoms can be caused by less serious conditions, they should never be ignored,” he said.
Ongoing abdominal pain or cramping is one warning sign that could warrant earlier screenings. (iStock)
Rectal bleeding in particular should always be taken seriously, even in younger patients, Cannon said.
“Too often, symptoms are attributed to hemorrhoids, diet, stress or athletic activity without further evaluation,” he noted. “Any persistent or unexplained bleeding warrants a conversation with a physician, and in some cases, a colonoscopy.”
“If something feels new, persistent, or concerning, don’t wait. Early evaluation can save your life.”
Certain genetic conditions
Some common hereditary syndromes increase the risk of colorectal cancer and may warrant earlier screenings.
For example, people with Lynch syndrome — an inherited DNA mutation that greatly increases lifetime risk — should get a colonoscopy every one to two years starting at about 20–25 years old or two to five years before the youngest diagnosed family case, according to the National Cancer Institute.
Familial Adenomatous Polyposis (FAP), another genetic variant, carries the risk of thousands of polyps and a nearly 100% lifetime risk of CRC, noted the American Cancer Society. Those with FAP are advised to start annual screenings at as early as 10 to 12 years old.
Several other syndromes and genetic variations — including Peutz–Jeghers Syndrome, Juvenile Polyposis Syndrome and MUTYH-Associated Polyposis (MAP) — can also warrant earlier screenings.
Inflammatory bowel disease
Those with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease, face a higher lifetime risk of developing colorectal cancer, according to the Centers for Disease Control and Prevention.
CLICK HERE FOR MORE HEALTH STORIES
This is largely due to chronic inflammation that causes cellular changes. In this case, the patient may be advised to start colonoscopy screenings before age 45.
If someone falls into a category that warrants an early screening before 45, and then the screening is normal, the length of time until the next one will depend on the specific risk factors, according to Martin.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“If it was performed because of a strong family history, repeating it every five years is common,” he advised. “If the person turns out not to have colon cancer (or an advanced polyp) and is closer to average risk than to high risk, the interval may be longer.”
In many cases, early screenings will be covered by insurance, Martin said, but coverage rules can differ depending on whether the exam is classified as screening or diagnostic.
Those with inflammatory bowel disease, including ulcerative colitis and Crohn’s disease, face a higher lifetime risk of developing colorectal cancer. (iStock)
“Under federal law, recommended screening tests for average-risk patients are generally covered without cost-sharing, but a colonoscopy done because of symptoms is often considered diagnostic, as mentioned above,” he noted. “This can have an impact on deductibles or co-pays. The exact out-of-pocket cost varies by insurer and plan.”
The encouraging news is that colorectal cancer is often preventable, Cannon emphasized.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“Most cancers develop slowly from precancerous polyps over many years,” he said. “Screening allows physicians to detect and remove these polyps before they turn into cancer.”
“The key message: If something feels new, persistent, or concerning, don’t wait. Early evaluation can save your life.”
Medical expert analyzes trending IV therapy, concerns about peptides
Dr. Mike Varshavski joins ‘Fox & Friends’ for Wellness Week, examining trending self-care treatments. He evaluates IV vitamin therapy, highlighting its hospital-critical role versus unproven benefits for general wellness, citing potential risks like vitamin imbalance. Dr. Mike also differentiates creatine, a research-backed supplement, from unregulated peptides marketed with unverified anti-aging and muscle growth promises, urging caution for patients.
NEWYou can now listen to Fox News articles!
We are officially living in the “maxxing” era.
From “looksmaxxing” to improve appearance to “sleepmaxxing” for better rest, these viral terms all point to the same goal: squeezing every ounce of potential out of a specific trait or habit.
With a growing focus on optimizing wellness and maximizing longevity, the trend has evolved into what’s known as “humanmaxxing,” sparking a bigger question: How far can people go to optimize the human body?
ANTI-AGING BENEFITS LINKED TO ONE SURPRISING HEALTH HABIT
While there is no single definition of humanmaxxing, the trend generally refers to efforts to optimize health, performance and longevity through a combination of lifestyle habits, health tracking, supplements and, in some cases, more experimental interventions.
While there is no single definition of humanmaxxing, the trend generally refers to efforts to optimize health, performance and longevity through a combination of lifestyle habits, health tracking, supplements and, in some cases, more experimental interventions. (iStock)
For some, the movement begins with biohacking. According to Dave Asprey, a Texas-based wellness expert who refers to himself as the “father of biohacking,” optimizing your body starts with changing your environment.
Asprey has defined biohacking as “the art and science of changing the environment around you or inside you so that you have full control of your own biology.”
COULD HUMANS LIVE TO BE 150 YEARS OLD? GENETICIST SHARES WHY IT MAY BE POSSIBLE
His public advice focuses on boosting cellular energy through everyday choices like intermittent fasting, high-fat diets, red-light therapy and supplement routines.
“My goal right now is 180 years, because I’m doing something about it now instead of waiting,” he once said.
Clinical experts warn that extreme self-experimentation skips the rigorous safety checks that typical medical science requires. (iStock)
Others have embraced a more data-driven approach. Tech entrepreneur Bryan Johnson, creator of the multimillion-dollar longevity project Blueprint in Los Angeles, argues that optimizing the body means removing human error from health decisions and instead relying on medical data.
“Methodically, we sought to build an algorithm with science and data that could better care for me than I can myself,” Johnson wrote on his website. “My mind did not have the authority to override the algorithm.”
THINKING ABOUT PEPTIDES? DOCTORS REVEAL KEY DOS AND DON’TS AS ‘WILD WEST’ MARKET GROWS
Johnson’s routine involves tracking hundreds of health metrics, eating a precisely measured diet, taking dozens of supplements, and undergoing advanced medical treatments in an effort to reduce his biological age.
CLICK HERE FOR MORE HEALTH STORIES
At the far end of the spectrum are those investing in technologies aimed at pushing the limits of human performance.
London-based tech investor Christian Angermayer recently described humanmaxxing as a strategy toward human maximization.
Tech entrepreneur Bryan Johnson, creator of the multimillion-dollar longevity project Blueprint, argues that optimizing the body means removing human error from health decisions and instead relying on medical data. (iStock)
“I don’t think we should become something different, because I think humans are awesome, but I think we can maximize the potential [that] is already in us,” he said in an interview with The New York Times.
Angermayer’s investment firm, Apeiron Investment Group, focuses on technologies intended to help people “live longer, healthier and more fulfilling lives.” He also founded atai Life Sciences, a biotechnology company that develops psychedelic treatments for mental health conditions that are currently being evaluated in clinical trials.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
As interest in humanmaxxing grows, mainstream health experts urge consumers to separate evidence-based wellness practices from experimental interventions.
Public guidance from the National Institute on Aging notes that while some anti-aging therapies have shown promise in laboratory research, there is not yet sufficient evidence that they can safely extend human life.
As interest in humanmaxxing grows, mainstream health experts urge consumers to separate evidence-based wellness practices from experimental interventions. (iStock)
Clinical experts also caution that extreme self-experimentation can bypass the rigorous safety standards applied to conventional medical treatments.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
According to the Endocrine Society, taking substances such as testosterone or growth hormone without a medical need can lead to serious health risks, including cardiovascular complications and long-term disruption of the body’s chemical balance.
While many humanmaxxing habits overlap with standard healthy lifestyle practices, experts say consumers should be cautious of expensive or experimental interventions that promise dramatic anti-aging or longevity benefits without strong scientific evidence.
NEWYou can now listen to Fox News articles!
A new test could make it easier to detect high-risk prostate cancer cases earlier.
The blood test, called Stockholm3, is showing promise in clinical trials, beating out the traditional, standard prostate-specific antigen (PSA) test.
In a new study published in the Annals of Internal Medicine, researchers from the Karolinska Institutet in Sweden studied the test’s efficacy in more than 12,000 men — mostly Swedish or European — aged 50 to 74.
NEW PROSTATE CANCER TEST PINPOINTS DISEASE BETTER THAN PSA OPTION, STUDY FINDS
All participants were tested with PSA and Stockholm3 and were followed for two years. During the follow-up period, 443 men were diagnosed with aggressive prostate cancer.
Stockholm3 detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests.
Stockholm3 detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests. (iStock)
Stockholm3 missed “significantly fewer” serious cancer cases than PSA. The number of men incorrectly classified as high-risk was similar across both tests, according to a press release.
Thorgerdur Palsdottir, a researcher at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, wrote in a statement that one of the major challenges in prostate cancer is being able to identify the cases that are “truly dangerous.”
‘DILBERT’ CREATOR’S DESPERATE PLEA SHINES SPOTLIGHT ON ALTERNATIVE PROSTATE CANCER DRUG
“Our results show that Stockholm3 identifies significantly more aggressive cancer cases than PSA without increasing the number of unnecessary follow-ups,” she said.
“These results point toward a potential change in how prostate cancer screening can be conducted,” the researcher added. “A more precise blood test could enable earlier detection of aggressive disease while reducing the number of unnecessary follow-up examinations and procedures.”
“A more precise blood test could enable earlier detection of aggressive disease while reducing the number of unnecessary follow-up examinations and procedures,” a researcher commented. (iStock)
Study co-author Hari Vigneswaran, chief medical officer of Stockholm3-maker A3P Biomedical, commented on these “promising” findings in an interview with Fox News Digital.
PROSTATE CANCER SCREENING AFTER 70: EXPERTS QUESTION GUIDANCE AFTER BIDEN’S DIAGNOSIS
He confirmed that the PSA has been the standard for prostate cancer screening since the 1990s despite its “well-documented limitations.”
CLICK HERE FOR MORE HEALTH STORIES
“It leads to invasive and costly follow-up testing, contributes to over-diagnosis of non-aggressive cancers and, most importantly, it misses a substantial share of aggressive disease,” Vigneswaran said.
When aggressive prostate cancer is found while still confined in the prostate, the five-year survival is close to 100%. (iStock)
When aggressive prostate cancer is found while still confined in the prostate, the five-year survival rate is close to 100%, which highlights the importance of early detection, according to the doctor.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Data from the National Cancer Institute’s SEER database show that metastatic prostate cancer has risen over the past decade, suggesting that “we have not improved early detection of the aggressive, curable disease that screening is meant to catch,” Vigneswaran said.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“The goal of screening is to find the cancers that need treatment while they are still curable, without raising the number of men who screen positive but don’t have aggressive disease,” he said.
Stockholm3 could reduce the need for unnecessary MRIs and biopsies, according to the researcher. (Getty Images)
Stockholm3 could reduce the need for unnecessary MRIs and biopsies, according to the researcher.
The findings did have some limitations. Stockholm3 is an investigational device and is not available for sale in the U.S., Vigneswaran noted.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The test estimates a man’s risk of aggressive prostate cancer, but a biopsy remains the gold standard for confirming the disease.
The company plans to seek FDA approval to use the test for routine screening and will “generate the evidence needed to support that pathway, including U.S. data,” Vigneswaran said.
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
-
Pennsylvania6 seconds ago10 Best Small Towns In Pennsylvania For A Crowd-Free Summer
-
Rhode Island5 minutes agoVideo: Massive great white shark feeds on dead whale off the coast of Rhode Island
-
South-Carolina12 minutes agoSouth Carolina pitcher Will Craddock announces transfer to SEC program
-
South Dakota15 minutes agoTeam South Dakota gets strong performances at National Junior High Finals Rodeo
-
Tennessee20 minutes ago2026 Tennessee Football Position Preview: Running Backs | Rocky Top Insider
-
Texas27 minutes agoSisters, friend charged in Texas mom’s stabbing death
-
Utah30 minutes agoUtah Mammoth Announce 2026 Development Camp Roster | Utah Mammoth
-
Vermont35 minutes agoCommentary | Eric Peterson: Time is running out for Vermont
